arrow
K

Katherine Prieto

german cancer research center (dkfz)
H指数:9
被引数:341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
2025-02-040
OAAI
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates

非人灵长类动物R21疟疾疫苗的多种临床阶段佐剂的比较免疫学评估

2024-07-310
PRE
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein

VH3-33针对恶性疟原虫环子孢子蛋白的抗体的交叉反应性和效力的分子决定因素

2023-11-012
OAAI
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model (vol 8, 52, 2023)

基于糖基化纳米颗粒的PfCSP疫苗在小鼠疟疾模型中赋予持久的抗体反应和无菌保护 (vol 8,52, 2023)

2023-06-052
OAAI
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
2023-05-245
OA
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

基于糖基化纳米颗粒的PfCSP疫苗在小鼠疟疾模型中赋予持久的抗体反应和无菌保护

2023-04-079
OAAI
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
2021-06-1649
OAAI